DLEU1（13q14）基因探針
| 型 號(hào)： | |
| 報(bào) 價(jià)： |  |
DLEU1（13q14）基因探針 本試劑盒主要用于DLEU1（13q14）基因的檢測(cè)，里面包括即用型雜交液和DAPI復(fù)染劑。 本試劑盒僅供科研使用。
- 產(chǎn)品描述
DLEU1（13q14）基因探針
廣州健侖生物科技?有限公司
本司長(zhǎng)期供應(yīng)尼古丁（可替寧）檢測(cè)試劑盒，其主要品牌包括美國(guó)NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品，國(guó)產(chǎn)產(chǎn)品，試劑盒的實(shí)驗(yàn)方法是膠體金方法。
我司還有很多熒光原位雜交系列檢測(cè)試劑盒以及各種FISH基因探針和染色體探針等，。
DLEU1（13q14）基因探針
本試劑盒主要用于DLEU1（13q14）基因的檢測(cè)，里面包括即用型雜交液和DAPI復(fù)染劑。
本試劑盒僅供科研使用。
歡迎咨詢(xún)
歡迎咨詢(xún)
以下是我司出售的部分FISH產(chǎn)品：
| BCL6（3q37）基因斷裂探針 |
| 13/18/21/XY染色體計(jì)數(shù)探針 |
| XY染色體計(jì)數(shù)探針 |
| p53/RB1/ATM/CSP12/D13S25基因探針 |
| 5q33/5q31/D7S486/D7S522/CSP8/D20S108/XY基因探針 |
| 4/10/17/KMT2A[ETV6RUNX1]/[BCRABL(DF)]基因探針 |
| p53/D13S319/RB1/1q21/IGH基因探針 |
| 13/16/18/21/22/XY染色體計(jì)數(shù)探針 |
| ALK（2p23）基因斷裂探針 |
| EML4/ALK融合基因 t(2;2); inv(2) 探針 |
| 1p和19q探針 |
| KIT（4q12）基因探針（紅色） |
| SS18（18q11）（SYT）基因斷裂探針 |
| 乳腺癌染色體數(shù)目異常檢測(cè)探針 |
| C-MET（7q31）基因探針 |
二維碼掃一掃
【公司名稱(chēng)】 廣州健侖生物科技有限公司
【】 楊永漢
【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化宣傳】
Mr. Huang said that the special drug for treating Bray was actually listed in foreign countries as early as 2001, but has not been in the Chinese market. "This drug can not be bought at home, and in foreign countries is particularly expensive, even if bought can not afford to buy." Mr. Huang said.
Some rare diseases
Be included in the category of free aid
The reporter has learned that in recent years, with the attention of media, medical institutions, public welfare organizations and relevant government departments, more and more rare diseases have been gradually known to the public. Some rare diseases have also been paid attention to and are included in the category of free assistance.
Insiders said that the gene detection technique can effectively diagnosis and prevention of rare diseases in a certain range, the Mediterranean anemia, congenital deafness, maple diabetes, adrenal hyperplasia, ichthyosis, Duchenne muscular dystrophy, single gene genetic disease, can realize the "early warning" in the pre stage through genetic testing; congenital retinal ten pigmentosa rare disease, can be treated by gene technology; including phenylketonuria, hundreds of genetic diseases can be accuray diagnosed by gene detection technology, in order to intervene by diet and drugs etc. in daily life.
Ms. Chen, the care home of CMT (peroneal muscular atrophy), said he hoped that the public would be able to know and pay attention to rare diseases. Taking CMT as an example, the current organization found only 500 patients in the country. On the one hand, she hopes that the patient will face up to his illness, diagnose the disease and prevent the disease from being inherited. On the other hand, the data of the sick friend are very important for future drug research, pricing and health insurance.
